The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

Capricor Therapeutics is expected to release data from the phase 3 HOPE-3 trial in Q3'25, thus presenting a potential path ...

New bacterial mRNA vaccine technology shows promise in fighting plague, and could help address the global threat of antibiotic resistance through rapid vaccine development.

President Donald Trump has gone to great lengths in recent days to quash the Jeffrey Epstein fervor in his party. It doesn’t ...

Johnson & Johnson (JNJ) gets FDA priority review for TAR-200 gains, a drug releasing system targeting bladder cancer. Read ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

WASHINGTON — The Justice Department can publicly release its investigative report on President-elect Donald Trump's 2020 election interference case, a federal judge said Monday — the latest ...

Participants in trials of BrainStorm Cell Therapeutics' NurOwn filed a Citizens’ Petition with the FDA earlier this month ...